Structures by: Jeyaseelan S.
Total: 28
5-[(Benzo[<i>d</i>][1,3]dioxol-5-yl)methyl]-3-[4-(pyridin-2-yl)phenyl]-4,5-dihydroisoxazole
C22H18N2O3
IUCrData (2017) 2, 2 x170278
a=17.548(5)Å b=8.719(3)Å c=12.237(4)Å
α=90° β=108.380(9)° γ=90°
1-Benzylsulfonyl-1,2,3,4-tetrahydroquinoline
C16H17NO2S
Acta Crystallographica Section E (2015) 71, 4 o249-o250
a=13.5690(5)Å b=6.7128(2)Å c=16.8317(6)Å
α=90° β=110.2430(10)° γ=90°
1-Methanesulfonyl-1,2,3,4-tetrahydroquinoline
C10H13NO2S
Acta Crystallographica Section E (2015) 71, 1 o20
a=5.5865(2)Å b=9.2195(4)Å c=10.1924(4)Å
α=85.798(2)° β=84.686(2)° γ=77.166(2)°
1-Tosyl-1,2,3,4-tetrahydroquinoline
C16H17NO2S
Acta Crystallographica Section E (2014) 70, 11 o1176
a=8.2176(7)Å b=8.0468(6)Å c=22.2439(18)Å
α=90.00° β=98.107(4)° γ=90.00°
(4-Hydroxy-3,5-dimethylphenyl)(phenyl)methanone
C15H14O2
Acta Crystallographica Section E (2013) 69, 11 o1676
a=4.7741(13)Å b=15.198(4)Å c=17.274(5)Å
α=90° β=95.275(12)° γ=90°
1-[(6-Chloropyridin-3-yl)sulfonyl]-1,2,3,4-tetrahydroquinoline
C14H13ClN2O2S
Acta Crystallographica Section E (2015) 71, 6 660-662
a=6.5661(10)Å b=10.2595(18)Å c=11.3490(19)Å
α=69.101(7)° β=88.219(7)° γ=77.238(7)°
5-(1-Benzofuran-2-yl)-3-(4-methylphenyl)-4,5-dihydro-1,2-oxazol-5-ol
C18H15NO3
Acta Crystallographica Section E (2015) 71, 7 o492-o493
a=10.2200(15)Å b=14.2289(19)Å c=10.2474(15)Å
α=90° β=93.058(7)° γ=90°
2-(1,3-Benzodioxol-5-yl)-3-phenylquinazolin-4(3<i>H</i>)-one
C21H14N2O3
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 7 o1113
a=8.984(4)Å b=6.056(3)Å c=15.248(6)Å
α=90° β=95.357(6)° γ=90°
Ethyl 5-methyl-3-phenylisoxazole-4-carboxylate
C13H13NO3
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 6 o987
a=9.750(8)Å b=14.589(13)Å c=9.397(8)Å
α=90° β=116.872(13)° γ=90°
5-Methyl-3-phenylisoxazole-4-carboxylic acid
C11H9NO3
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 6 o897
a=11.953(4)Å b=5.981(2)Å c=14.142(5)Å
α=90° β=105.548(6)° γ=90°
1-Chloro-4-(3,4-dichlorophenyl)-3,4-dihydronaphthalene-2-carbaldehyde
C17H11Cl3O
Acta Crystallographica Section E (2011) 67, 2 o378
a=10.2969(5)Å b=10.8849(5)Å c=13.6144(7)Å
α=90.00° β=91.436(5)° γ=90.00°
1-{1-[2,8-Bis(trifluoromethyl)-4-quinolyl]-5-methyl-1<i>H</i>-1,2,3-triazol- 4-yl}ethanone
C16H10F6N4O
Acta Crystallographica Section E (2010) 66, 10 o2512-o2513
a=14.064(2)Å b=8.7275(13)Å c=27.468(4)Å
α=90.00° β=94.172(2)° γ=90.00°
1-(1-Benzofuran-2-yl)-3-(4-chlorophenyl)prop-2-en-1-one
C17H11ClO2
Acta Crystallographica Section E (2010) 66, 2 o466
a=15.9034(12)Å b=14.1393(12)Å c=5.9572(5)Å
α=90.00° β=93.039(4)° γ=90.00°
1,3-Bis(hydroxymethyl)benzimidazolin-2-one
C9H10N2O3
Acta Crystallographica Section E (2009) 65, 11 o2735
a=13.5515(14)Å b=11.0848(12)Å c=17.6253(19)Å
α=90.00° β=94.216(2)° γ=90.00°
Ethyl 2-(4-benzoyl-2,5-dimethylphenoxy)acetate
C19H20O4
Acta Crystallographica Section E (2009) 65, 11 o2854-o2855
a=8.148(4)Å b=8.635(4)Å c=13.029(7)Å
α=84.054(8)° β=81.176(8)° γ=66.559(7)°
Bis[<i>N</i>,<i>N</i>-dimethyl-1-(10<i>H</i>-pyrido[3,2- <i>b</i>][1,4]benzothiazin-10-yl)propan-2-aminium] tetrakis(thiocyanato-κ<i>N</i>)cobaltate(II)
2(C16H20N3S),C4CoN4S42
Acta Crystallographica Section E (2010) 66, 7 m772-m773
a=25.2420(4)Å b=11.4357(2)Å c=14.5939(2)Å
α=90.00° β=98.5570(10)° γ=90.00°
4-(Benzyloxy)phenyl 4-hexadecyloxy-3-methoxybenzoate
C37H50O5
Acta Crystallographica Section E (2011) 67, 4 o840
a=5.4507(2)Å b=9.7352(4)Å c=31.3738(14)Å
α=94.155(4)° β=94.261(4)° γ=95.576(4)°
3-Ethyl-6-(4-fluorophenyl)-7<i>H</i>-1,2,4- triazolo[3,4-<i>b</i>][1,3,4]thiadiazine
C12H11FN4S
Acta Crystallographica Section E (2012) 68, 6 o1860
a=13.322(3)Å b=13.017(3)Å c=7.1912(16)Å
α=90.00° β=105.308(4)° γ=90.00°
(<i>E</i>)-<i>N</i>'-Hydroxy-1,3-diphenyl-4,5-dihydro-1<i>H</i>-pyrazole-5- carboximidamide
C16H16N4O
Acta Crystallographica Section E (2012) 68, 6 o1661-o1662
a=7.845(11)Å b=8.940(12)Å c=11.116(15)Å
α=99.50(2)° β=99.76(2)° γ=106.70(2)°
(5,7-Dimethyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl diethyldithiocarbamate
C17H21NO2S2
Acta Crystallographica Section E (2012) 68, 6 o1657
a=7.8570(2)Å b=23.7745(5)Å c=9.7684(2)Å
α=90.00° β=109.4830(10)° γ=90.00°
<i>N</i>-[3-(4-Fluorobenzyl)-2,4-dioxo-1,3-diazaspiro[4.5]dec-8-yl]- 2-methylbenzenesulfonamide
C22H24FN3O4S
Acta Crystallographica Section E (2012) 68, 1 o105-o106
a=5.8314(3)Å b=26.3603(11)Å c=13.8558(7)Å
α=90.00° β=98.623(5)° γ=90.00°
<i>N</i>-{3-[2-(4-Fluorophenoxy)ethyl]-2,4-dioxo-1,3-diazaspiro[4.5]decan- 7-yl}-4-methoxybenzenesulfonamide
C23H26FN3O6S
Acta Crystallographica Section E (2012) 68, 1 o194-o195
a=11.926(5)Å b=11.025(5)Å c=18.508(5)Å
α=90° β=97.271(5)° γ=90°
3-Ethyl-4-[(<i>E</i>)-(4-fluorobenzylidene)amino]-1<i>H</i>-1,2,4-triazole- 5(4<i>H</i>)-thione
C11H11FN4S
Acta Crystallographica Section E (2012) 68, 5 o1407
a=7.7967(17)Å b=8.4205(19)Å c=19.138(4)Å
α=90.00° β=99.780(4)° γ=90.00°
Methyl <i>N</i>-{4-[(4-methoxyphenoxy)methyl]-2-oxo-2<i>H</i>-chromen-7-yl}carbamate
C19H17NO6
Acta Crystallographica Section E (2012) 68, 6 o1734
a=8.31410(10)Å b=17.3978(3)Å c=11.5729(2)Å
α=90.00° β=94.3090(10)° γ=90.00°
4-[(<i>E</i>)-(4-Fluorobenzylidene)amino]-3-methyl-1<i>H</i>-1,2,4-triazole- 5(4<i>H</i>)-thione
C10H9FN4S
Acta Crystallographica Section E (2012) 68, 6 o1607
a=9.0048(19)Å b=10.811(2)Å c=12.729(3)Å
α=101.205(3)° β=103.899(3)° γ=112.376(3)°
(<i>Z</i>)-4-Benzylidene-3-methylisoxazol-5(4<i>H</i>)-one
C11H9NO2
Acta Crystallographica Section E (2012) 68, 11 o3091
a=12.144(4)Å b=6.734(2)Å c=12.333(4)Å
α=90° β=114.589(5)° γ=90°
(2<i>E</i>)-3-(2-Bromophenyl)-1-(5-bromothiophen-2-yl)prop-2-en-1-one
C13H8Br2OS
Acta Crystallographica Section E (2012) 68, 12 o3456
a=34.524(8)Å b=3.9994(9)Å c=23.428(5)Å
α=90.00° β=126.804(3)° γ=90.00°
5-{4'-[(5-Benzyl-2<i>H</i>-tetrazol-2-yl)methyl]biphenyl-2-yl}-1<i>H</i>-tetrazole monohydrate
C22H18N8,H2O1
Acta Crystallographica Section E (2013) 69, 5 o743-o744
a=14.7659(4)Å b=7.6507(3)Å c=18.2922(5)Å
α=90° β=97.153(2)° γ=90°